(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 5.04% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.17%.
Stevanato Group Spa's revenue in 2024 is $1,182,206,521.On average, 3 Wall Street analysts forecast STVN's revenue for 2024 to be $362,500,395,694, with the lowest STVN revenue forecast at $361,257,832,769, and the highest STVN revenue forecast at $364,140,893,712. On average, 3 Wall Street analysts forecast STVN's revenue for 2025 to be $391,649,898,312, with the lowest STVN revenue forecast at $389,170,829,312, and the highest STVN revenue forecast at $393,774,035,859.
In 2026, STVN is forecast to generate $431,792,887,829 in revenue, with the lowest revenue forecast at $425,872,316,250 and the highest revenue forecast at $437,713,459,408.